EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors

Chia-Chi Lin

Journal of Immunotherapy and Precision Oncology · 01.05.2021 · 4 (2) · 105-114

DOI: 10.36401/jipo-20-32 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Immunotherapy and Precision Oncology, online erschienen am 14.05.2021. Verfasst von Chia-Chi Lin. Beteiligte Einrichtung: Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophage infiltration has been identified as an independent poor prognostic factor for several cancers. Macrophages also orchestrate various tumor-promoting processes. This observation sparked an interest to therapeutically target these plastic innate immune cells. To date, blockade of colony-stimulating factor 1 (CSF1) or its receptor represents one of the selective approaches to manipulate tumor-associated macrophages. In this review, I discuss the efficacy and safety of various CSF1 receptor tyrosine kinase inhibitors, anti–CSF1 receptor monoclonal antibodies, and anti-CSF1 monoclonal antibodies in clinical development for patients with cancer and highlight potential combination partners, mainly anti–program cell death protein 1 (PD-1) and program cell death protein ligand 1 (PD-L1) antibodies.

Schlagwörter

Stichwörter der Autor:innen

colony-stimulating factor 1 receptortenosynovial giant cell tumortumor-associated macrophages

Autor:innen und Institutionen

  • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

Zitieren

APA

Lin, C. C. (2021). Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors. Journal of Immunotherapy and Precision Oncology, 4(2), 105-114. https://doi.org/10.36401/jipo-20-32

Vancouver

Lin CC. Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors. Journal of Immunotherapy and Precision Oncology. 2021;4(2):105-114. doi:10.36401/jipo-20-32

BibTeX
@article{Lin2021,
  author = {Lin, Chia-Chi},
  title = {Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors},
  journal = {Journal of Immunotherapy and Precision Oncology},
  year = {2021},
  volume = {4},
  number = {2},
  pages = {105--114},
  doi = {10.36401/jipo-20-32}
}
Kostenlos starten →